Home › NDC Lookup › RxCUI directory › RxCUI 2585221

0.9 ML triamcinolone acetonide 40 MG/ML Injection — RxCUI 2585221

Name: 0.9 ML triamcinolone acetonide 40 MG/ML Injection (RxCUI 2585221)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2585221 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2585221

Official name0.9 ML triamcinolone acetonide 40 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known astriamcinolone acetonide 40 MG per 0.9 ML Injection; triamcinolone acetonide 40 MG in 0.9 ML Injection

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)53 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triamcinolone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Yes, intra-articular triamcinolone is specifically approved to give short-term relief for knee arthritis, gout flares, bursitis, and similar joint conditions. The extended-release...
I'm getting a triamcinolone injection in my knee. Will it actually help, and how long does it last?
That's a really important thing to flag with your doctor before your injection or prescription. Triamcinolone can raise blood sugar — even in people whose diabetes is well-controll...
I have diabetes. Should I be worried about using triamcinolone?

📖 Read our full Triamcinolone guide →

🕸️ Concept Web — How 0.9 ML triamcinolone acetonide 40 MG/ML Injectio... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.9 ML triamcinolone acetonide 40 MG/ML Injection RxCUI 2585221 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Triamcinolone 10759 IN
- Triamcinolone acetonide 10761 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Xipere 2585222 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Triamcinolone Injection 1792143 SCDF
- Triamcinolone acetonide Injection 2649170 SCDFP
- Triamcinolone Injectable Product 1158224 SCDG
- Triamcinolone acetonide Injectable Product 2663063 SCDGP
- Triamcinolone Injection [Xipere] 2585225 SBDF
- Triamcinolone acetonide Injection [Xipere] 2656563 SBDFP
- Xipere Injectable Product 2585224 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Triamcinolone acetonide 40 MG/ML 1085753 SCDC
- 0.9 ML triamcinolone acetonide 40 MG/ML Injection [Xipere] 2585226 SBD
- Triamcinolone acetonide 40 MG/ML [Xipere] 2585223 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Triamcinolone acetonide 40 MG/ML SCDC · 1085753
Triamcinolone Injection SCDF · 1792143
Triamcinolone acetonide Injection SCDFP · 2649170
Triamcinolone Injectable Product SCDG · 1158224
Triamcinolone acetonide Injectable Product SCDGP · 2663063

Brand-Name Concepts

0.9 ML triamcinolone acetonide 40 MG/ML Injection [Xipere] SBD · 2585226
Triamcinolone acetonide 40 MG/ML [Xipere] SBDC · 2585223
Triamcinolone Injection [Xipere] SBDF · 2585225
Triamcinolone acetonide Injection [Xipere] SBDFP · 2656563
Xipere Injectable Product SBDG · 2585224
Xipere BN · 2585222

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 2585221 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
24208-0040-01	1 TRAY in 1 CARTON (24208-040-01) / 1 VIAL in 1 TRAY / .9 m...	Xipere	Bausch & Lomb Incorporated	2021-12-17
24208-0040-40	1 TRAY in 1 CARTON (24208-040-40) / 1 VIAL in 1 TRAY / .9 m...	Xipere	Bausch & Lomb Incorporated	2021-12-17

Observed labelers: Bausch & Lomb Incorporated (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3299	Inj xipere 1 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.